Clinical Trial Update: Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating 64Cu-ATSM PET/CT in cervical cancer was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• 64Cu-ATSM

Snippet

Sponsor: American College of Radiology | Conditions: Cervical Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-01-28